Pacific Biosciences
PACB
PACB
205 hedge funds and large institutions have $246M invested in Pacific Biosciences in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 53 increasing their positions, 71 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
25% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 71
33% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 45
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
205
Holding in Top 10
1
Calls
$2.16M
Puts
$2.62M
Top Buyers
| 1 | +$3.21M | |
| 2 | +$3.05M | |
| 3 | +$1.24M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.16M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.13M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$8.22M | |
| 3 | -$6.69M | |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$3.43M |
| 5 |
Morgan Stanley
New York
|
-$3.15M |
